ReviewMolecular biotechnology2026
Targeting Cancers with Microrobots and Bacteriobots.
Review in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- What Does Bacteria Have to Do with Cancer? The Influence of the Body's Microbiota on Cancer in Cats and Dogs.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Developing efficient medication delivery systems is a key area of research that will improve the efficacy of cancer treatments. As cancer cells have certain characteristics, it is crucial to precisely deliver chemotherapeutic drugs to the tumor microenvironment without harming healthy tissues. There has been a growing interest in exploiting biological agents to overcome the disadvantages of traditional cancer treatments in targeting and delivering drugs. These technologies utilize specific properties of the tumor microenvironment, such as the availability of excess glucose. This review discusses the current understanding of microrobots for cancer treatment with a special focus on bacteriobots. Bacteriobots are excellent candidates for smart cancer therapy because they can respond to particular cues from the tumor microenvironment. Similarly, microrobots include bacteriobots and other miniature materials/devices for the precise and specific targeting of cancer cells. Here, we discuss synthetic and biohybrid microrobots. It is imperative to make further technological advancements so that they can be employed on a large scale for cancer treatment.
Indexed as
Identifiers
40770161What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.